Dexcom Inc. Stock
€110.48
Your prediction
Dexcom Inc. Stock
Pros and Cons of Dexcom Inc. in the next few years
Pros
Cons
Performance of Dexcom Inc. vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Dexcom Inc. | 0.550% | 4.740% | 3.156% | 5.495% | 6.210% | 126.000% | 718.370% |
Baxter International | 0.590% | 0.382% | -3.792% | -48.753% | -22.834% | -48.256% | -33.757% |
Stryker Corp. | 0.140% | 0.934% | 5.686% | 7.460% | 13.157% | 97.487% | 91.889% |
Henry Schein Inc. | 1.310% | 1.519% | -4.583% | -8.171% | -1.751% | 74.191% | 38.158% |
Comments
News

Manitoba Becomes a Provincial Trailblazer in Providing Simplified Access to Advanced Glucose Monitors
Dexcom, Inc. (NASDAQ: DXCM), a global leader in real-time continuous glucose monitoring (rtCGM) for people with diabetes, announced that its Dexcom G6 CGM System will be available to people of all

DexCom Comments on SVB Relationship
DexCom, Inc. (NASDAQ: DXCM), today issued the following statement in response to speculation following the developments at Silicon Valley Bank, including a recent CNBC article:
“Dexcom does not

Dexcom Announces Upcoming Conference Presentations
DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on the company at the following upcoming investor conferences:
-
Sean Christensen, Vice President, Finance and